麻豆传媒

Oncology/Hematology >

Lymphoma

News, opinions and meeting coverage in oncology/hematology.

A photo of the Georgia World Conference Center with the acronym AACR overlaid.

Durable Responses With Keytruda in Later-Line SCLC

Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent

Do Keloids Convey a Higher Cancer Risk?

Taiwanese researchers show association between raised scars and cancers

Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

ASH Poster Rounds: Adding BTK Inhibitor Safe in First-Line MCL

Plus: Lenalidomide upfront in PTCL; skipping RT in primary mediastinal B-cell lymphoma

Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapies

Studies test addition of targeted agents, immunotherapy

CAR T-Cell Responses Prove Durable in ALL, DLBCL

Two studies demonstrate long-term control in relapsed/refractory disease

Cutting Chemo Cycles Feasible in Younger DLBCL Patients

Patients, ages 18-60, fare well with four cycles of CHOP instead of six

Sneak Peek at Practice-Changing Research From ASH 2018

"Big trials, big results," plus sickle cell disease and CAR T-cell therapies

FDA Approves Rituximab Biosimilar for NHL

Indications for front line or beyond, single agent or combination

FDA Warns Against Long-Term Zmax Use in Certain Cancer Patients

Heightened risk of relapse, death seen in study of stem cell transplant recipients

Ditching Chemo Appears Viable in Frontline Follicular Lymphoma

PFS 'nearly identical' at 3 years with novel immunomodulatory combination

Morning Break: Stolen Trump Records; Gyns in Trouble; Eye Cancer Cluster?

Health news and commentary from around the Web gathered by the 麻豆传媒 staff

NCCN: Don't Let HIV Status Dictate Cancer Treatment

New guidelines focus on most common cancers in HIV-infected patients

Vince DeVita鈥檚 Oncology Opus

Medicine and music share center stage in storied career

Lymphoma Case Reported in MS Patient on Aubagio

First case in medical literature, more found in global surveillance reports

MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

Bangladesh-Boston Collaborate on ASCT Center

Two dozen patients undergo successful stem cell transplant in Dhaka

Reassuring Cancer Data With JIA Tx

No apparent increase in risk with anti-TNF treatment

Opinion Makers: Jury Still Out on Gene-Guided DLBCL Therapy

Rationale for subtyping, but treatment data inconclusive

Rheumatoid Factor Tied to Sjogren's Lymphoma

Disease activity also contributed to blood cancer risk in Sjogren's syndrome

ASCO: Gazyva Doubles Average Remission Time in NHL

Obinutuzumab delays progression in rituximab-refractory indolent disease.

Part 2: Oncologists Weigh In on PBS Cancer Documentary

Six specialists share their impressions of Ken Burns' cancer opus.

Are Your Patients Using Fake Names?

A case study in the American Journal of Medicine poses a vexing question many healthcare professionals have faced: What should you do when your patients use fraudulent names?

Jakafi Requires Careful Dosing Early: Experts

NEW YORK -- The JAK inhibitor can make a big difference for myelofibrosis patients, but must be monitored.

OncoBlog: Driving the CAR to a Cancer Cure?

Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the Medpage Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.

Lab Notes: Meth May Worsen Fungal Infection

Mice injected with methamphetamine and exposed to Cryptococcus fungi showed more extensive and hard-to-eradicate infections. Also this week: an organic pesticide fights parasitic worms.

Sjogren's Carries Heavy Disease Burden

BIRMINGHAM, England -- Patients with primary Sjogren's syndrome are prone to develop serious complications over the long term, despite the presumption that this is a relatively benign autoimmune disease, a 25-year review found.

New Combo Replaces CHOP for Lymphoma

ATLANTA - The combination chemotherapy known as CHOP, used for nonHodgkin's lymphoma, is rapidly being replaced by bendamustine (Treanda), frequently combined with rituximab (Rituxan), researchers reported.

ASCO: Low-Dose Radiation OK in CNS Lymphoma

CHICAGO -- Whole-brain radiation at about half the standard dose is safe and effective after chemotherapy for patients with primary central nervous system lymphoma, researchers are reporting.

Clinical Notes: Beware the Seat Heater

麻豆传媒 debuts a new regular feature, a roundup of clinical news you might otherwise have missed. This week we led with a report that heated car seats can leave passengers with "toasted skin syndrome."

AMA Adopts Policies on Circumcision, Gun Safety

The American Medical Association (AMA) House of Delegates has adopted a number of new policies at its interim meeting, including policies on male circumcision, physician discussion of gun safety, and a new medical coding system that will go into effect in 2013.

Red Sox Rookie Pitcher to Get Chemo for Non-Hodgkin's Lymphoma

BOSTON -- The anaplastic large cell lymphoma diagnosed in Boston Red Sox rookie pitcher Jon Lester, detected by his uncle, is a childhood non-Hodgkin's lymphoma, a high-grade malignancy with a favorable clinical course.